A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease

Journal of Clinical Psychiatry

Volumn 66, Issue 7, 2005, Pages 940-947

  Papassotiropoulos, Andreas ^a   Wollmer, M Axel ^a   Tsolaki, Magdalini ^b   Brunner, Fabienne ^a   Molyva, Dimitra ^b   Lütjohann, Dieter ^c   Nitsch, Roger M ^a   Hock, Christoph ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LIPASE; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; APOLIPOPROTEIN E5; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL DERIVATIVE; CYTOCHROME; CYTOCHROME P450 46A1; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; FEMALE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION;

EID: 22744456176     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v66n0720     Document Type: Article

References (29)

1. Evans DA, Smith LA, Scherr PA, et al. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 1991;134:403-412
2. Assal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol 2002; 15:445-450
3. Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000;57:968-976
4. Risch N, Merikangas K. The future of genetic studies of complex human diseases [letter]. Science 1996;273:1516-1517
5. Silverman JM, Smith CJ, Marin DB, et al. Identifying families with likely genetic protective factors against Alzheimer disease. Am J Hum Genet 1999;64:832-838
6. Gatz M, Pedersen NL, Berg S, et al. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 1997;52:M117-M125
7. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65: 220-228
8. Wolozin B. Cholesterol and the biology of Alzheimer's disease. Neuron 2004;41:7-10
9. Michikawa M. The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol. Mol Neurobiol 2003;27:1-12
10. Baum L, Chen L, Masliah E, et al. Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet 1999;88:136-139
11. Brune S, Kolsch H, Ptok U, et al. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J Neural Transm 2003;110:1041-1050
12. Csaszar A, Kalman J, Szalai C, et al. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease. Neurosci Lett 1997;230:151-154
13. Lambert JC, Pasquier F, Cottel D, et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998;7:533-540
14. Lendon CL, Talbot CJ, Craddock NJ, et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997;222: 187-190
15. Luedecking-Zimmer E, DeKosky ST, Chen Q, et al. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet 2002;111:443-451
16. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003;60: 29-35
17. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Ann Rev Med 1996;47:387-400
18. Scacchi R, Gambina G, Martini MC, et al. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern. Dement Geriatr Cogn Disord 2001;12:63-68
19. Wollmer MA, Streffer JR, Tsolaki M, et al. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry 2003;8:635-638
20. Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res 2001;11: 2115-2119
21. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
22. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), pt 1: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39: 1159-1165
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
24. Papassotiropoulos A, Lutjohann D, Bagli M, et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002;36:27-32
25. Nauck M, Hoffmann MM, Wieland H, et al. Evaluation of the apo E genotyping kit on the LightCycler. Clin Chem 2000;46:722-724
26. Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 2002;7:899-902
27. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155:945-959
28. Hyman BT. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiol Aging 1997;18:S27-S32
29. McGeer PL, McGeer EG. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001;58:1790-1792